Pesquisa | Portal de Pesquisa da BVS Enfermagem

1.

Pralsetinib in patients with RET fusion-positive non-small-cell lung cancer: A plain language summary of the ARROW study.

Griesinger, Frank; Curigliano, Giuseppe; Subbiah, Vivek; Baik, Christina S; Tan, Daniel Sw; Lee, Dae H; Misch, Daniel; Garralda, Elena; Kim, Dong-Wan; van der Wekken, Anthonie J; Gainor, Justin F; Paz-Ares, Luis; Liu, Stephen V; Kalemkerian, Gregory P; Bowles, Daniel W; Mansfield, Aaron S; Lin, Jessica J; Smoljanovic, Vlatka; Rahman, Ahmadur; Zalutskaya, Alena; Louie-Gao, Melinda; Boral, Andy L; Mazières, Julien.

Future Oncol ; 20(6): 297-306, 2024 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-37916501

2.

Exposure-Response Relationships for Pralsetinib in Patients with RET-Altered Thyroid Cancer or RET Fusion-Positive Nonsmall Cell Lung Cancer.

Kassir, Nastya; McDougall, David; Kuruvilla, Denison; Kim, Sean; Kumar, Shaun; Rahman, Ahmadur; Ruf, Thorsten; Cheeti, Sravanthi; Ankrom, Wendy.

J Clin Pharmacol ; 64(6): 685-696, 2024 Jun.

Artigo em Inglês | MEDLINE | ID: mdl-38337106

3.

Statistical inferences under step stress partially accelerated life testing based on multiple censoring approaches using simulated and real-life engineering data.

Rahman, Ahmadur; Kamal, Mustafa; Khan, Shahnawaz; Khan, Mohammad Faisal; Mustafa, Manahil SidAhmed; Hussam, Eslam; Atchadé, Mintodê Nicodème; Al Mutairi, Aned.

Sci Rep ; 13(1): 12452, 2023 Aug 01.

Artigo em Inglês | MEDLINE | ID: mdl-37528103

4.

Parameter Estimation in Step Stress Partially Accelerated Life Testing under Different Types of Censored Data.

Kamal, Mustafa; Siddiqui, Sabir Ali; Rahman, Ahmadur; Alsuhabi, Hassan; Alkhairy, Ibrahim; Barry, Thierno Souleymane.

Comput Intell Neurosci ; 2022: 3491732, 2022.

Artigo em Inglês | MEDLINE | ID: mdl-35528329

5.

Type 2 diabetes and risk of pancreatic adenocarcinoma.

Rahman, Ahmadur.

Lancet Oncol ; 15(10): e420, 2014 Sep.

Artigo em Inglês | MEDLINE | ID: mdl-25328944

6.

Sunitinib for atypical and anaplastic meningioma.

Rahman, Ahmadur.

Lancet Oncol ; 15(10): e424, 2014 Sep.

Artigo em Inglês | MEDLINE | ID: mdl-25328951

7.

Maintenance pazopanib in ovarian cancer.

Rahman, Ahmadur.

Lancet Oncol ; 15(12): e530, 2014 Nov.

Artigo em Inglês | MEDLINE | ID: mdl-25602100

8.

Quality of life with treated acute promyelocytic leukaemia.

Rahman, Ahmadur.

Lancet Oncol ; 15(12): e533, 2014 Nov.

Artigo em Inglês | MEDLINE | ID: mdl-25602107

9.

Vemurafenib and cobimetinib in BRAF-mutated melanoma.

Rahman, Ahmadur.

Lancet Oncol ; 15(12): e535, 2014 Nov.

Artigo em Inglês | MEDLINE | ID: mdl-25602110

10.

Prediction model for heart failure in childhood cancer survivors.

Rahman, Ahmadur.

Lancet Oncol ; 15(12): e537, 2014 Nov.

Artigo em Inglês | MEDLINE | ID: mdl-25602114

11.

FOLFOXIRI and bevacizumab in metastatic colorectal cancer.

Rahman, Ahmadur.

Lancet Oncol ; 15(13): e590, 2014 Dec.

Artigo em Inglês | MEDLINE | ID: mdl-25499288

Portal de Pesquisa da BVS Enfermagem

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar:

Pralsetinib in patients with RET fusion-positive non-small-cell lung cancer: A plain language summary of the ARROW study.

Exposure-Response Relationships for Pralsetinib in Patients with RET-Altered Thyroid Cancer or RET Fusion-Positive Nonsmall Cell Lung Cancer.

Statistical inferences under step stress partially accelerated life testing based on multiple censoring approaches using simulated and real-life engineering data.

Parameter Estimation in Step Stress Partially Accelerated Life Testing under Different Types of Censored Data.

Type 2 diabetes and risk of pancreatic adenocarcinoma.

Sunitinib for atypical and anaplastic meningioma.

Maintenance pazopanib in ovarian cancer.

Quality of life with treated acute promyelocytic leukaemia.

Vemurafenib and cobimetinib in BRAF-mutated melanoma.

Prediction model for heart failure in childhood cancer survivors.

FOLFOXIRI and bevacizumab in metastatic colorectal cancer.